Cephalon induced Teva not to enter the market with a cheaper generic version in exchange for a package of commercial side-deals beneficial to Teva and some cash payments, European Commission Executive Vice-President Margrethe Vestager told a news conference.
The agreement with Teva to delay the market entry of the generic drug Modafinil after Cephalon’s main patents had...